You may also like
Sequential Electrocardiographic Analysis of Stone Heart Syndrome in a Patient Supported Six Days With LVAD
Abstract: A 21-year-old male patient underwent aortic and mitral valve replacement for progressive cardiac failure due to acute bacterial endocarditis. Ischemic myocardial […]
Open Forum on Platelet Therapy & Clinical & Feasible Regenerative Medicine Treatment Options in the OR (EP Video)
The regenerative medicine market today includes first of all platelet-rich plasma (PRP) products, brought to market by a large variety of medical companies (52:34 minutes).
Hybrid Extracorporeal Membrane Oxygenation
Veno-venous (VV) and veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) therapy is widely used in critically ill patients with refractory cardiogenic shock and cardiac arrest or suffering from severe respiratory failure. Besides traditional ECMO cannulation, changes in patients' conditions or the occurrence of specific complications (i.e., cerebral hypoxia or left ventricular dilation) may require modifications in cannulation strategies or the combination of ECMO with additional invasive or minimally invasive procedures, to improve organ function and ECMO efficiency.
